Moderna said on Monday that low-dose COVID-19 vaccines are safe and appear to work at ages 6-11. This is because manufacturers have joined rival Pfizer and are demonstrating a move towards expanding injections into children.
Pfizer child-sized vaccine doses are widely used. They have been evaluated by the Food and Drug Administration for young people aged 5 to 11 years in about the same age group and may be available by early November. The company’s vaccine has already been approved for people over the age of 12.
Moderna has not yet been approved to provide the vaccine to teens, but while waiting, it is studying low doses for young children.
The researchers tested two shots of children aged 6 to 11 years, each containing half the dose given to adults, at monthly intervals. Preliminary results showed that vaccinated children developed antibodies that fight the same level of virus that young adults produce after shooting at full power, Moderna said in a news release.
The study enrolled 4,753 children aged 6 to 11 years who received either the vaccine or dummy shots. Moderna said that vaccinated young people, like adults, have temporary side effects such as fatigue, headaches, fever, and pain at the injection site.
This study was too small to find very rare side effects, such as occasional heart inflammation, mainly among young men, after either the Moderna or Pfizer vaccines.
Moderna has not released any further details and has not submitted its data to scientific journals, but said it will soon share the interim results with the FDA and global regulators. The study is still underway and the company will actually prevent infection in children unless there are enough COVID-19 cases to compare the proportion of vaccinated and unvaccinated participants. I can’t calculate the effectiveness of my vaccine.
The FDA has not yet decided on its application to extend vaccination from 12 to 17 years old, but in some countries it has cleared Moderna’s adolescent vaccination.
However, if the FDA approves low doses of the Pfizer vaccine between the ages of 5 and 11, the United States will begin vaccination of children under the age of 12 sometime next month. Pfizer proved last week that its child-sized dose was nearly 91% effective in preventing symptomatic COVID-19 in its age group, despite the widespread prevalence of highly contagious delta variants. I reported that it was done.
FDA advisers will weigh Pfizer’s evidence at a public meeting on Tuesday. If the agency approves Pfizer’s child shots, the Centers for Disease Control and Prevention the following week is set up to recommend who should receive them.
The Associated Press’s Department of Health Sciences is supported by the Department of Science Education at the Howard Hughes Medical Institute. AP is solely responsible for all content.
Copyright 2021 AP communication. all rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
According to Moderna, low-dose COVID shots work well for children aged 6-11 years.news
Source link According to Moderna, low-dose COVID shots work well for children aged 6-11 years.news